Biostatistics: A Review of Phase II Trial Designs for Initial Marker Validation

A review of phase II trial designs for initial marker validation.

By Sumithra J. Mandrekar, Ming-Wen An, Daniel J. Sargent

Contemp Clin Trials. 2013 May 8. pii: S1551-7144(13)00068-2. doi: 10.1016/j.cct.2013.05.001. [Epub ahead of print]

Event Information

Date & Time(s)
Wednesday, October 23, 2013, 4:00 PM – 5:00 PM

Memorial Sloan Kettering Cancer Center
Survivorship, Outcomes and Risk Program
Seminar Series


This program is open to the research community.

Location Information

Memorial Sloan Kettering Cancer Center
307 East 63rd Street
3rd Floor Conference Room
New York, NY 10065